Company: HURA
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0000950170-25-047921
Chunk: 279

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1B
Chunk 279
---
 31,

        December 31,

        2024

        2023

        Furniture and fixtures
         
        $
        170,607

        $
        170,607

        Leasehold improvements

        544,629

        544,628

        Machinery and office equipment

        1,423,183

        1,365,277

        Software

        72,394

        72,394

        2,210,813

        2,152,906

        Less accumulated depreciation and amortization

        (2,087,447
        )

        (1,970,736
        )

        $
        123,366

        $
        182,170

       Depreciation and amortization of property and equipment totaled approximately $117,000 and $177,000 for the years ended December 31, 2024, and 2023, respectively.

Note 9—Accounts payable and accrued expensesAccounts payable and accrued expenses consist of the following as of December 31, 2024, and 2023:  

        December 31,

        December 31,

        2024

        2023

        Trade accounts payable
         
        $
        3,152,816

        $
        1,866,762

        Accrued compensation

        1,161,650

        1,415,397

        Other accrued expenses

        855,700

        156,400

        $
        5,170,166

        $
        3,438,559

Note 10—Convertible promissory notesOn various dates beginning on December 11, 2023 through September 18, 2024, the Company completed a private placement in which the Company issued Convertible Promissory Notes (the “Notes”) with various entities at various amounts for an aggregate of $31,253,000. The Notes bear interest at a rate of twenty percent (20%) per annum and were scheduled to mature on the second anniversary of the issuance date. In addition, the investors in the private placement also received common stock purchase warrants 

F-18

TUHURA BIOSCIENSES, INC AND SUBSIDIARIESNotes to the consolidated financial statementsFor the years ended December 31, 2024, and 2023  

(the “2024 Warrants”) in the event they subscribe to purchase Notes in the